Abstract
We describe a 14-year-old bone marrow transplant recipient who was anti-HBs-positive before the procedure and afterwards developed acute infection with hepatitis B virus (HBV). Liver biopsies taken while symptomatic showed portal fibrosis progressing to cirrhosis. The patient responded to lamivudine treatment with HBeAg seroconversion and significant regression of fibrosis. Although the source and timing of HBV exposure remain unclear, the potential for severe hepatitis B infection following bone marrow transplant warrants caution. This case demonstrates that a symptomatic HBV infection can occur in an immunocompromised patient who had originally been anti-HBs-positive.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Blanpain C, Knoop C, Delforge ML et al. Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies: report on three cases and review of the literature Transplantation 1998 66: 883 886
Dhedin N, Douvin C, Kuentz M et al. Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc Transplantation 1998 66: 616 619
Martin BA, Rowe JM, Kouides PA, DiPersio JF . Hepatitis B reactivation following allogeneic bone marrow transplantation: case report and review of the literature Bone Marrow Transplant 1995 15: 145 148
Yotsuyanagi H, Yasuda K, Iino S et al. Persistent viremia after recovery from self-limited acute hepatitis B Hepatology 1998 27: 1377 1382
Penna A, Artini M, Cavalli A et al. Long-lasting memory T cell respones following self-limited acute hepatitis B J Clin Invest 1996 98: 1185 1194
Iwai K, Tashima M, Itoh M et al. Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressed period Bone Marrow Transplant 2000 25: 105 108
Altfeld M, Rochstroh JK, Addo M et al. Reactivation of hepatitis B in a long-term anti-HBs-positive patient with AIDS following lamivudine withdrawal J Hepatol 1998 29: 306 309
Ahmed A, Keeffe EB . Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection Am J Gastroenterol 1999 94: 249 251
ter Borg F, Smorenburg S, de Man R et al. Recovery from life-threatening, corticosteroid-unresponsive, chemotherapy-related rectivation of hepatitis B associated with lamivudine therapy Dig Dis Sci 1998 43: 2267 2270
Lai CL, Chien RN, Leung NW et al. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group New Engl J Med 1998 339: 61 68
Dienstag J, Perrillo R, Schiff E et al. A preliminary trial of lamivudine for chronic hepatitis B infection New Engl J Med 1995 333: 1657 1661
Perrillo R, Rakela J, Dienstag J et al. Multicenter study of lamivudine therapy for hepatitis B after liver transplantation Hepatology 1999 29: 1581 1586
Lau G, Yuen S, Au W et al. Histological changes during clearance of chronic hepatitis B virus infection by adoptive immunity transfer J Gastroenterol Hepatol 1999 14: 262 268
Acknowledgements
Dr Yeung is the recipient of a Fellowship from the Canadian Institutes of Health Research/Health Canada Hepatitis C Initiative. We thank Dr Wendy Lau, Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, for assistance with the blood donor trace-back.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yeung, L., Petric, M., Cutz, E. et al. Histological improvement with lamivudine therapy for de novo hepatitis B occurring in an anti-HBs-positive child after bone marrow transplantation. Bone Marrow Transplant 30, 459–462 (2002). https://doi.org/10.1038/sj.bmt.1703675
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703675